Why Lower Drug Prices Benefit Institutional Investors General ReflectionsAdam SeitchikMay 25, 2007Drug prices, fiduciary duty, health care costs, pharmaceutical pricing, shareholder activism, shareholder resolutions, socially responsible investing, universal ownersComment
Climate Change From the Investor’s Perspective General ReflectionsAdam SeitchikJuly 25, 2005climate changeComment
